Neoplasia/BPH

	Mechanisms of resistance to antibody-drug conjugates in bladder cancer. Front Pharmacol Liu K, Xu F, Wu C, Wang M. PMID: 42676452 [PubMed]
	Diagnostic value of whole-tumor ADC histogram parameters combined with ISUP grade and MRI-EPE score for predicting extracapsular extension in PI-RADS 4-5 prostate cancer. Front Oncol Yi L, Gu Y, Xie X, Wang W, Yan X, Zhao Y. PMID: 42676395 [PubMed]
	The impact of different exercise modalities on health-related quality of life in patients with prostate cancer undergoing androgen deprivation therapy: a systematic review and network meta-analysis. Front Oncol Li W, Huang X, Huang X, Shi Y, Wang F, Pu L, He M, Tan H. PMID: 42676391 [PubMed]
	Use of androgen suppression therapy at salvage radiotherapy in recurrent prostate cancer: a systematic review with meta-analysis. Front Urol Chaves Medina MJ, Varela Ramírez R, Donoso Donoso W, Moreno-Chaparro J, Eslava-Schmalbach J. PMID: 42676340 [PubMed]
	[Value Of Bone Scintigraphy To Mdp-Tc 99m In The Management Of Prostate Cancer At The Institute Of Radioisotopes Of Niamey]. Mali Med Moussa Issoufou D, Ousmane Manzo MS, Boka Tounga Y, Adamou SH, Oumarou KM, Amadou S. PMID: 42676326 [PubMed - indexed for MEDLINE]
	HERMES trial supports shortened SBRT schedule without added toxicity for patients with prostate cancer. Cancer Lawrence L. PMID: 42676121 [PubMed - in process]
	Association Between Menopausal Hormone Therapy and the Risk of Urologic Cancer: A National Population-Based Retrospective Cohort Study in Korea. J Korean Med Sci Yuk JS, Yoon SH, Cho DY, Oh N, Kim JY. PMID: 42676073 [PubMed - indexed for MEDLINE]
	Evaluation of Predictive Factors for Prostate Cancer Detection in PI-RADS 2 Lesions. Urol J Tunçekin A, Köse M, Akta, Arslan E. PMID: 42676051 [PubMed - indexed for MEDLINE]
	Multi-task Deep Learning via UNETR for PSMA PET/CT Image for Prostate Cancer: Simultaneous Assessment of Prostate Cancer Disease Burden, Treatment Selection and Survival Outcomes. J Imaging Inform Med Tun HM, Naing L, Malik OA, Abdullah MS, Ta T, Rahman HA. PMID: 42675275 [PubMed - as supplied by publisher]
	Survival and Mortality Predictors in Prostate Cancer: A Retrospective Cohort of 10â€‰556 Brazilian Patients. Cancer Rep (Hoboken) Grippa WR, Dell'Antonio LS, Dell'Antônio CS, Salaroli LB, Lopes-Júnior LC. PMID: 42674784 [PubMed - indexed for MEDLINE]
	Practical consensus document on the use of [Â¹â·â·Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer. Rev Esp Med Nucl Imagen Mol (Engl Ed) Álvarez Mena N, Gómez-Grande A, Nogareda Seoane Z, Prado Wohlwend S, Rodríguez Fernández A, Rodríguez Fraile M, Vercher Conejero JL, Mitjavila Casanovas M. PMID: 42674318 [PubMed - as supplied by publisher]
	[HIFU: Best Practices for Optimal Performance]. Aktuelle Urol Salomon G, Heckmann N, Hohenhorst JL, Ekrutt J, Palec J, Nagaraj Y. PMID: 42673977 [PubMed - indexed for MEDLINE]
	[Focal Therapy for Prostate Cancer in Germany: Progress or Illusion?]. Aktuelle Urol Schostak M, Borkowetz A. PMID: 42673976 [PubMed - indexed for MEDLINE]
	[Which Focal Therapy for Whom and When?]. Aktuelle Urol Borkowetz A, Schostak M. PMID: 42673975 [PubMed - indexed for MEDLINE]
	Comparative cost-effectiveness of robot-assisted versus open prostatectomy: a real-life nationwide study. J Robot Surg Préaubert N, Bénard A, Blin P, Jové J, Bladou F, Piazza L, Robert G. PMID: 42671716 [PubMed - indexed for MEDLINE]
	Three-dimensional image guidance using instrument tracking facilitates intraoperative resection-line determination during robot-assisted partial nephrectomy. J Robot Surg Tsukino K, Kobayashi S, Koura M, Takamatsu D, Nagakawa S, Tsukahara S, Tanegashima T, Matsumoto T, Shiota M, Oki E, Eto M. PMID: 42671671 [PubMed - indexed for MEDLINE]
	Pelvic floor muscle training for erectile function in men undergoing radical prostatectomy: a systematic review of randomized controlled trials. World J Urol Akdagcik Z, Aybal HÇ, Karaaslan M, Guven S, Tunc L, Yilmaz M. PMID: 42671634 [PubMed - indexed for MEDLINE]
	Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial. Prostate Freedland AR, Moriera DM, Gong J, Freedland SJ. PMID: 42671204 [PubMed - as supplied by publisher]
	Long-Term Oncologic Outcomes of Neoadjuvant Tumor-Directed Immunotherapy (PROSTVAC) Before Radical Prostatectomy for Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Trial. Prostate Millan B, Kenigsberg AP, Hesswani C, Koller CR, Parikh SH, Blake Z, Fu H, Blachman-Braun R, Michael P, Gurram S, Turkbey B, Parnes H, Karzai F, Donahue RN, Schlom J, Gulley J, Pinto PA. PMID: 42671172 [PubMed - as supplied by publisher]
	Comparative Prognostic Impact of Two-Dimensional and Three-Dimensional Computed Tomography-Based Sarcopenia Indices in Metastatic Castration-Sensitive Prostate Cancer. Int J Urol Hori T, Iwamoto H, Inaba T, Nakagawa R, Kamijima T, Kano H, Makino T, Naito R, Kadomoto S, Yaegashi H, Shigehara K, Nohara T, Izumi K, Mizokami A. PMID: 42670789 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 190933

Page 1 of 9547



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy